Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

Trial Profile

Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
  • Indications Acute coronary syndromes; Thromboembolism
  • Focus Pharmacodynamics
  • Acronyms TEGCOR
  • Most Recent Events

    • 20 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.
    • 20 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
    • 04 Apr 2016 Status changed from recruiting to discontinued due to slow enrolment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top